1.
Vogler JB 3rd,
Murphy WA.
Bone marrow imaging.
Radiology 1988; 168:679–693.
2.
Travlos GS.
Normal structure,
function,
and histology of the bone marrow.
Toxicol Pathol 2006; 34:548–565.
3.
Politis C,
Karamerou A,
Block M.
Pathophysiologic aspects of the bone/marrow/fat relationship.
Lab Management 1983;21:40–55.
4.
Piney A.
The anatomy of the bone marrow: with special reference to the distribution of the red marrow.
BMJ 1922;28:792–795.
5.
Hashimoto M.
Pathology of bone marrow.
Acta Haematol 1962;27:193–216.
6.
Snyder WS,
Cook MJ,
Nasset ES,
et al.
In: ICRP,
editors.
International commission on radiological protection.
Report of the Task Group on Reference Man.
Oxford 1975;85–98.
7.
Ricci C,
Cova M,
Kang YS,
et al.
Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study.
Radiology 1990;177:83–88.
8.
Baur A,
Staber A,
Arbogast S,
et al.
Acute osteonecrotic and neoplastic vertebral compression fractures: fluid sign at MR imaging.
Radiology 2002;225:730–735.
9.
Baur A,
Staber A,
Bruning R,
et al.
Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathological vertebral compression fractures.
Radiology 1998;207:349–356.
10.
Yuh WTC,
Zachar CK,
Barloon,
et al.
Vertebral compression fractures: distinction between benign and malignant causes with MR imaging.
Radiology 1989;172:215–218.
11.
Baker LL,
Goodman SB,
Perkash I,
et al.
Benign versus pathological compression fractures of vertebral bodies assessment with conventional spine-echo,
chemical shift and STIR imaging.
Radiology 1990;174:495–502.
12.
Howe BM,
Johnson GB,
Wenger DE.
Current concepts in MRI of focal and diffuse malignancy of bone marrow.
Semin Musculoskelet Radiol 2013;17(2):137–144.
13.
Simpfendorfer CS,
Ilaslan H,
Davies AM,
James SL,
Obuchowski NA,
Sundaram M.
Does the presence of focal normal marrow fat signal within a tumor on MRI exclude malignancy? An analysis of 184 histologically proven tumors of the pelvic and appendicular skeleton.
Skeletal Radiol 2008;37(9):797–804.
14.
Hanrahan CJ,
Shah LM.
MRI of Spinal Bone Marrow: Part 2,
T1-Weighted Imaging-Based Differential Diagnosis.
AJR 2011; 197:1309–1321.
15.
Del Grande F,
Santini F,
Herzka DA,
Aro MR,
Dean CW,
Gold GE,
et al.
Fat suppression techniques for 3T MR Imaging of the musculoeskeletal system.
RadioGraphics 2014; 34:217-233.
16.
Maeder Y,
Dunet V,
Richard R,
Becce F,
Omoum P.
Bone Marrow Metastases: T2- weighted Dixon Spin-Echo Fat Images Can Replace T1-weighted Spin-Echo Images.
Radiology 2018; 000:1–12.
17.
Disler DG,
McCauley TR,
Ratner LM,
et al.
In-phase and out-of- phase MR imaging of bone marrow: prediction of neoplasia based on the detection of coexistent fat and water.
AJR Am J Roentgenol 1997;169:1439–1447.
18.
Wismer GL,
Rosen BR,
Buxton R,
et al.
Chemical shift imaging of bone marrow: preliminary experience.
AJR Am J Roentgenol 1985; 145:1031–1037.
19.
Zampa Z,
Cosottini M,
Michelassi MC,
et al.
Value of opposed- phase gradient-echo technique in distinguishing between benign and malignant vertebral lesions.
Eur Radiol 2002;12:1811–1818.
20.
Del Grande F,
Tatizawa-Shiga N,
Farahani SJ,
Chalian M,
Fayad LM.
Chemical shift imaging: preliminary experience as an alternative sequence for defining the extent of a bone tumor.
Quant Imaging Med Surg 2014;4(3):173-180.
21.
Erly WK,
Oh ES,
Outwater EK.
The utility of in-phase/opposed-phase imaging in differentiating malignancy from acute benign compression fractures of the spine.
AJNR Am J Neuroradiol 2006;27:1183-8.
22.
Zajick DC,
Morrison WB,
Schweitzer ME,
et al.
Benign and malignant processes: normal values and differentiation with chemical shift MR imaging in vertebral marrow.
Radiology 2005;237:590-6.
23.
Eito K,
Waka S,
Naoko N,
Makoto A,
Atsuko H.
Vertebral Neoplastic Compression Fractures: Assessment by Dual-Phase Chemical Shift Imaging.
J.
Magn.
Reson.
Imaging 2004;20:1020-1024.
24.El-Samie HE-K,
El-Ghany HSA.
The value of added opposed/in phase MRI sequences in characterization of the focal vertebral bone marrow lesions in oncology patients.
Egypt J Radiol Nucl Med 2015;46:727-732.
25.Yoo HJ,
Hong SH,
Kim DH,
Choi J,
Chae HD,
Jeong BM,
et al.
Measurement of Fat Content in Vertebral Marrow Using a Modified Dixon Sequence to Differentiate Benign from Malignant Processes.
J.
Magn.
Reson.
Imaging 2016.
26.
Fayad LM,
Jacobs MA,Wang X,
et al.
Musculoskeletal tumors: how to use anatomic,
functional,
and metabolic MR techniques.
Radiology 2012;265:340-56.
27.
Dreizin D,
Ahlawat S,
Del Grande F,
Fayad LM.
Gradient-echo in-phase and opposed-phase chemical shift imaging: Role in evaluating bone marrow.
Clinical Radiology 69 (2014) 648-657.
28.
Del Grande F,
Subhawong T,
Flammang A,
Fayad LM.
Chemical shift imaging at 3 Tesla: effect of echo time on assessing bone marrow abnormalities.
Skeletal Radiol 2014;43:1139–1147.
29.
Maas M,
Hollak CE,
Akkerman EM,
Aerts JM,
Stoker J,
Den Heeten GJ.
Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.
AJR Am J Roentgenol.
2002; 179(4): 961-5.
30.
Georgy BA.
Metastatic spinal lesions: state of the art treatment options and future trends.
AJNR Am J Neuroradiol 2008;29:1605–1611.
31.
Krishnaney AA,
Steinmetz MP,
Benzel EC.
Biomechanics of metastatic spine cancer.
Neurosurg Clin N Am 2004;15:375–380.
32.
Martel Villagrán J,
Bueno Horcajadas A,
Pérez Fernández E,
Martín Martín S.
Precisión de la resonancia magnética en la diferenciación entre lesión vertebral maligna y benigna: papel de las secuencias de difusión,
del cociente fuera de fase/en fase y de los valores del coeficiente de difusión aparente.
Radiología 2015;57(2):142-149.
33.
Costelloe CM,
Kundra V,
Ma J,
Chasen BA,
Rohren EM,
Bassett RL et al.
Fast Dixon Whole-Body MRI for Detecting Distant Cancer Metastasis: A Preliminary Clinical Study.
J Magn Reson Imaging.
2012; 35(2): 399-408.